Smith Group Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Smith Group Asset Management's RMD Position: Q3 2026 in Review
Smith Group Asset Management reduced its ResMed (RMD) stake by 2.3% in Q3 2026, selling an estimated $6.54K and leaving 1,260 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #139.
Smith Group Asset Management first reported a position in RMD in Q2 2013 and has held it in 13 quarters since. The position peaked at $53.8M in Q3 2013. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Smith Group Asset Management held 1,260 shares of ResMed worth $279K as of Q3 2026.
- Smith Group Asset Management sold 30 ResMed shares in Q3 2026, an estimated $6.54K.
- ResMed made up 0.02% of Smith Group Asset Management's portfolio in Q3 2026, its #139 holding.
- Smith Group Asset Management first reported a position in ResMed in Q2 2013 and has held it in 13 quarters since.
- Smith Group Asset Management's ResMed position peaked at $53.8M in Q3 2013.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Smith Group Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.